|
|
MedDRA SubscribersThe MSSO prides itself on MedDRA being a subscriber-driven product. We welcome and encourage comments and questions on any item related to MedDRA. FeedbackTo ensure the MSSO continues to serve the needs of the user community, we continually strive to listen and gain ideas about directions for growth within MedDRA. Whether it is a concept paper developed by a member of the MSSO, a joint collaboration with a MedDRA interest group, a proposed standard, a hot topic, or other areas of growth, we value all feedback. We look forward to hearing from you. Transition Date for the Next MedDRA VersionPer the MedDRA Management Board endorsed, "best practice" on MedDRA versioning for single case reporting, the implementation (change-over) date for a new version of MedDRA is the first Monday of the second month following the release, at midnight GMT (Sunday to Monday), as follows:
Activities & EventsThe MSSO is involved in attending and hosting various Activities & Events throughout the year. We enjoy being able to provide you specific information about these events and encourage participation whenever feasible. In this section, you find where members of the MedDRA MSSO have spoken, previous and upcoming MSSO User Group meetings and Blue Ribbon Panel meetings, etc. |
Important Dates MedDRA Version 16.1 Freeze Date Updated "Points to Consider" Documents based on MedDRA Version 16.0 are now Available (1 April 2013) MedDRA Version 16.0 Language Translations Released MedDRA Version 16.0 Released MedDRA Messenger Implementation date for MedDRA v16.0 AnnouncementsSMQ Hypersensitivity Will Go into Production with MedDRA Version 16.0 (March 2013)
MedDRA Version Analysis Tool (MVAT) Is Now Available
Proposed Neoplasm SOC Changes - Explanatory Note and Spreadsheets Legacy Codes of Earlier Terminologies Removed |
mssohelp@mssotools.com |
MedDRA MSSO |
![]() |
![]() |